Provided by Tiger Trade Technology Pte. Ltd.

Anavex Life Sciences

2.42
+0.01000.41%
Post-market: 2.420.00000.00%19:30 EDT
Volume:920.59K
Turnover:2.23M
Market Cap:224.27M
PE:-16.74
High:2.45
Open:2.42
Low:2.38
Close:2.41
52wk High:10.38
52wk Low:2.26
Shares:92.67M
Float Shares:91.12M
Volume Ratio:1.32
T/O Rate:1.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1446
EPS(LYR):-0.5438
ROE:-12.80%
ROA:-9.70%
PB:1.99
PE(LYR):-4.45

Loading ...

PVG Asset Management announces plan for first 100 days at Anavex

TIPRANKS
·
Sep 18

PVG says Glass Lewis recommends Anavex shareholders vote for two nominees

TIPRANKS
·
Sep 18

Glass Lewis Recommends Anavex Stockholders to Vote for PVG’s Director Nominees

Reuters
·
Sep 18

Pvg Asset Management: Glass Lewis Recommends for Pvg Nominees Hogue, Kolbert; Against Incumbents Ma, Van Der Velden

THOMSON REUTERS
·
Sep 18

Pvg Asset Management: Glass Lewis Recommends Avxl Stockholders Vote Gold Universal Proxy Card at Sept 24, 2026 Meeting

THOMSON REUTERS
·
Sep 18

ISS Backs Anavex Board Slate, Urges Vote for All Six Director Nominees in Proxy Fight with PVG

Reuters
·
Sep 14

Anavex Says FDA Grants Meeting Request on Adding Pediatric Patients to Phase 3 Rett Syndrome Trial of Blarcamesine

Reuters
·
Sep 10

PVG Calls for Replacing Anavex Board, Hiring "Experienced" CEO

Reuters
·
Sep 10

Pvg : Calls for Replacement of Anavex Board and Hiring of "Experienced" CEO

THOMSON REUTERS
·
Sep 09

Pvg: We Do not Believe Anavex Can Obtain Funding They Need to Advance Blarcamesine Phase 2B/3 Trial with Existing Team

THOMSON REUTERS
·
Sep 09

Anavex Schedules Sept. 9 Investor Call to Outline Clinical Development Strategy and Priorities

Reuters
·
Sep 08

PVG calls for ‘meaningful board refreshment’ at Anavex

TIPRANKS
·
Sep 04

Pvg Asset Management- Nominates Six Director Candidates for Anavex Board

THOMSON REUTERS
·
Sep 04

Anavex Life Sciences Regains Nasdaq Compliance After Filing Quarterly Reports

MT Newswires Live
·
Sep 03

Anavex regains compliance with exchange filing rules

TIPRANKS
·
Sep 03

Anavex Regains NASDAQ Compliance After Filing Overdue Quarterly Reports

Reuters
·
Sep 03

Anavex Life Sciences Regains Compliance with NASDAQ Periodic Filing Requirement

THOMSON REUTERS
·
Sep 03

Anavex Life Sciences Regains Compliance with Nasdaq Periodic Filing Requirement

GlobeNewswire
·
Sep 03

Anavex Restates Fy2025 Internal Control Audit Opinion, Posts Net Loss of $46.38 Million

Reuters
·
Aug 29

Anavex Swings to FY26 Q3 Net Income of $7.82 Million

Reuters
·
Aug 25